Longitudinal Measures of Leptin in Pregnant Women Who Developed Preeclampsia
|ClinicalTrials.gov Identifier: NCT01649167|
Recruitment Status : Completed
First Posted : July 25, 2012
Last Update Posted : July 25, 2012
Background: Obesity in pregnancy is increasing and is a risk factor for metabolic pathology such as preeclampsia. Leptin is an adipokine which has a direct relationship to obesity.
Aim: to measure leptin in lean, obese and diabetic pregnant women at three months intervals throughout their pregnancies.
Methods: Pregnant women were recruited in the 1st trimester of pregnancy, and three groups were formed: a) with pregestational Body Mass Index (BMI) less than 25 kg/m2, b) BMI higher than 25 kg/m2 and c) with Gestational Diabetes Mellitus (GDM). Serum levels of leptin were measured with radioimmunoassay (RIA) technique.
|Condition or disease|
Show Detailed Description
|Study Type :||Observational|
|Actual Enrollment :||55 participants|
|Official Title:||Longitudinal Measures of Leptin in Pregnant Women Who Developed Preeclampsia|
|Study Start Date :||February 2009|
|Study Completion Date :||November 2010|
Pregnant women with overweight/obesity
Pregnant women with gestational diabetes
Pregnant women with normal weight
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01649167
|Principal Investigator:||Verónica Jackeline García Solorio, MSc||Autonomous University of the State of Mexico|
|Study Chair:||Hugo Mendieta Zerón, PhD||Autonomous University of the State of Mexico|